James Craigie - Apr 18, 2023 Form 4 Insider Report for Bloomin' Brands, Inc. (BLMN)

Role
Director, Chairman
Signature
/s/ Kelly Lefferts, Attorney in Fact
Stock symbol
BLMN
Transactions as of
Apr 18, 2023
Transactions value $
$0
Form type
4
Date filed
4/20/2023, 07:53 PM
Previous filing
Feb 13, 2023
Next filing
Aug 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLMN Common Stock Options Exercise $0 +231 +0.5% $0.00 46.6K Apr 18, 2023 Direct
transaction BLMN Common Stock Options Exercise $0 +9.72K +20.85% $0.00 56.4K Apr 18, 2023 Direct
transaction BLMN Common Stock Options Exercise $0 +5.26K +9.33% $0.00 61.6K Apr 18, 2023 Direct
transaction BLMN Common Stock Options Exercise $0 +2.47K +4% $0.00 64.1K Apr 18, 2023 Direct
holding BLMN Common Stock 4.04K Apr 18, 2023 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLMN Restricted Stock Units Award $0 +9.24K $0.00 9.24K Apr 18, 2023 Common Stock 9.24K $0.00 Direct F2, F3, F4
transaction BLMN Restricted Stock Units Options Exercise $0 -231 -100% $0.00* 0 Apr 18, 2023 Common Stock 231 $0.00 Direct F2, F4, F5
transaction BLMN Restricted Stock Units Options Exercise $0 -9.72K -100% $0.00* 0 Apr 18, 2023 Common Stock 9.72K $0.00 Direct F2, F4, F6
transaction BLMN Restricted Stock Units Options Exercise $0 -5.26K -100% $0.00* 0 Apr 18, 2023 Common Stock 5.26K $0.00 Direct F2, F4, F7
transaction BLMN Restricted Stock Units Options Exercise $0 -2.47K -50% $0.00 2.47K Apr 18, 2023 Common Stock 2.47K $0.00 Direct F2, F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held in trust for the benefit of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein, and inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of such shares for purposes of Section 16 or for any other purpose.
F2 Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.
F3 These RSUs, in the original grant amount of 9,236, will fully vest immediately prior to the issuer's annual meeting of stockholders in 2024.
F4 This field is not applicable.
F5 On April 18, 2022, the Compensation Committee approved a $5,000 increase to the annual equity grant for the non-executive Chair of the Board. These RSUs will vest in full on the date of the first annual meeting of stockholders following the grant date.
F6 These RSUs, in the original grant amount of 9,723, will fully vest immediately prior to the issuer's annual meeting of stockholders in 2023.
F7 These RSUs, in the original grant amount of 15,776, vest in three equal installments immediately prior to the issuer's annual meeting of stockholders each year beginning in 2021.
F8 These RSUs, in the original grant amount of 7,400, vest in three equal installments immediately prior to the issuer's annual meeting of stockholders each year beginning in 2022.